Takeda Pharmaceutical Co., Ltd.
0
0
0%

Financials

Cash flow

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Operating activities 327.7B 289.9B 196.3B 376.6B
Net income -11.7B 124.3B -103.1B 23.8B
Depreciation 185.0B 181.6B 189.8B 187.0B
Deferred taxes 39.9B 26.4B -4.2B 2.6B
StockBased compensation 18.7B 16.5B 17.6B 18.3B
Other non cash items 90.4B -53.0B 103.6B 75.8B
Accounts receivable -9.8B 48.1B -13.9B 12.7B
Accounts payable
Other assets liabilities 15.2B -54.0B 6.4B 56.5B
Investing activities -38.6B -11.1B 19.9B -108.5B
Capital expenditures -40.1B -41.5B -48.8B -45.1B
Net intangibles -12.7B -27.2B -43.9B -11.6B
Net acquisitions 417M 29.3B 67.7B 1.3B
Purchase of investments -1.6B -215M -2.1B -67.6B
Sale of investments 2.9B 1.1B 2.8B 3.6B
Other investing activity -267M 186M 313M -685M
Financing activities 69.7B -244.2B -266.9B -620.2B
Long term debt issuance 342.5B 183.6B 0 40B
Long term debt payments 35.8B -183.5B -548.0B -510.9B
Short term debt issuance -295.7B -46.0B 344.5B 0
Common stock issuance
Common stock repurchase 0 -51.6B -50.0B 0
Common dividends -8.8B -145.3B -9.7B -145.5B
Other financing charges -4.1B -1.3B -3.7B -3.8B
End cash position 681.5B 350.0B 385.1B 494.1B
Income tax paid
Interest paid
Free cash flow 325.4B 140.4B 129.4B 327.1B
Access the full /cash_flow historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 10 hours 18 minutes

22:41
00:00
09:00
15:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 15:30
All times are displayed in the Asia/Tokyo timezone (JST, UTC+09:00).